Skip to main content
. 2021 Sep 17;12:729424. doi: 10.3389/fphar.2021.729424

TABLE 1.

Dose escalation in the single ascending dose study.

Subjects (n = 40) Dose administered
Cohort 1 (n = 8, 6:2) Dose 1 Dose 4
5 mg 100 mg
Cohort 2 (n = 8, 6:2) Dose 2 Dose 5
25 mg 200 mg
Cohort 3 (n = 8, 6:2) Dose 3 Dose 6
50 mg 400 mg
Cohort 4 Elderly cohort (n = 16, 12:4) Dose A Dose B
50 mg 150 mg